Aims & Scope
In recent years a
breakthrough has occurred in our understanding of the molecular pathomechanisms
of human diseases whereby most of our diseases are related to intra and
intercellular communication disorders. The concept of signal transduction
therapy has got into the front line of modern drug research, and a
multidisciplinary approach is being used to identify and treat signaling
disorders.
The journal publishes
timely in-depth/mini reviews, research article and drug clinical trial studies
in the field of signal transduction therapy. Thematic issues are also published
to cover selected areas of signal transduction therapy. Coverage of the field
includes genomics, proteomics, medicinal chemistry and the relevant diseases
involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases.
Current
Signal Transduction Therapy is an essential journal for all involved in
drug design and discovery.
